January 16, 2025
TOPLINE: Trastuzumab emtansine (T-DM1) demonstrates sustained improvement in invasive disease-free survival and reduced the risk for death in human epidermal growth factor receptor 2 (HER2)-positive breast […]
January 16, 2025
When Gury Doshi, MD, learned that a patient’s insurance didn’t cover her breast cancer medication, Doshi had a potential workaround. The patient could try to bypass […]
January 16, 2025
Gene therapy has been available since 2022 for hemophilia B and since 2023 for hemophilia A, yet some major medical institutions have barely treated any patients […]
January 16, 2025
When it comes to naming the dietary patterns offering the most protection against cancer, plant-based diets emerge as the winner for reducing the risk for several […]
January 15, 2025
TOPLINE: In patients with recurrent small hepatocellular carcinoma (HCC), stereotactic body radiotherapy (SBRT) demonstrated superior local progression-free survival (PFS) and tumor control at 3 years compared […]
January 15, 2025
TOPLINE: In a retrospective study of 315 patients with relapsed/refractory multiple myeloma, retreatment with previously refractory drugs achieved an overall response rate of 56.2% and median […]
January 15, 2025
TOPLINE: CD37, a surface protein present on most acute myeloid leukemia (AML) blasts, demonstrates unique internalization properties that enable targeted drug delivery with minimal impact on […]
January 14, 2025
TOPLINE: Overall, obesity at the time of cancer diagnosis is independently associated with worse survival outcomes in pediatric patients. The association, however, varied by cancer type […]
January 14, 2025
TOPLINE: Physical activity before stage I cancer diagnosis is associated with reduced risk for disease progression and mortality. Members engaging in at least 60 minutes of […]